Blocking function of allergen-specific immunoglobulin G, F(ab')2, and Fab antibodies prepared from patients undergoing Dermatophagoides pteronyssinus immunotherapy

Nelson, 2011, Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults, J Allergy Clin Immunol, 127, 72, 10.1016/j.jaci.2010.11.035 Till, 2004, Mechanisms of immunotherapy, J Allergy Clin Immunol, 113, 1025, 10.1016/j.jaci.2004.03.024 Wachholz, 2002, Grass pollen immunotherapy for hayfever is associated with increases in local nasal but not peripheral Th1:Th2 cytokine ratios, Immunology, 105, 56, 10.1046/j.1365-2567.2002.01338.x Lin, 2018, IL-10 indirectly downregulates IL-4-induced IgE production by human B cells, Immunohorizons, 2, 398, 10.4049/immunohorizons.1800076 Feng, 2020, Allergen immunotherapy–induced immunoglobulin G4 reduces basophil activation in house dust mite–allergic asthma patients, Front Cell Dev Biol, 8, 30, 10.3389/fcell.2020.00030 Lam, 2020, Mechanisms of allergen-specific immunotherapy for allergic rhinitis and food allergies, Biosci Rep, 40, 10.1042/BSR20200256 Shamji, 2017, Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers, J Allergy Clin Immunol, 140, 1485, 10.1016/j.jaci.2017.10.010 Flicker, 2003, Renaissance of the blocking antibody concept in type I allergy, Int Arch Allergy Immunol, 132, 13, 10.1159/000073260 van Neerven, 2006, IgE-mediated allergen presentation and blocking antibodies: regulation of T-cell activation in allergy, Int Arch Allergy Immunol, 141, 119, 10.1159/000094714 Nouri-Aria, 2004, Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity, J Immunol, 172, 3252, 10.4049/jimmunol.172.5.3252 Wachholz, 2003, Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy, J Allergy Clin Immunol, 112, 915, 10.1016/S0091-6749(03)02022-0 Agache, 2020, Efficacy and safety of treatment with dupilumab for severe asthma: a systematic review of the EAACI guidelines—recommendations on the use of biologicals in severe asthma, Allergy, 75, 1058, 10.1111/all.14268 Bousquet, 2008, Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen), Allergy, 63, 8, 10.1111/j.1398-9995.2007.01620.x Bateman, 2008, Global strategy for asthma management and prevention: GINA executive summary, Eur Respir J, 31, 143, 10.1183/09031936.00138707 Feng, 2018, Functional and immunoreactive levels of IgG4 correlate with clinical responses during the maintenance phase of house dust mite immunotherapy, J Immunol, 200, 3897, 10.4049/jimmunol.1701690 Shamji, 2006, The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses, J Immunol Methods, 317, 71, 10.1016/j.jim.2006.09.004 Şahin, 2016, Mechanism of action of allergen immunotherapy, Am J Rhinol Allergy, 30, 1, 10.2500/ajra.2016.30.4367 Zissler, 2020, Predicting success of allergen-specific immunotherapy, Front Immunol, 11, 1826, 10.3389/fimmu.2020.01826 Eckl-Dorna, 2019, Allergen-specific antibodies regulate secondary allergen-specific immune responses, Front Immunol, 9, 3131, 10.3389/fimmu.2018.03131 Aalberse, 2009, Immunoglobulin G4: an odd antibody, Clin Exp Allergy, 39, 469, 10.1111/j.1365-2222.2009.03207.x Lai, 2013, Specific IgG4 production during house dust mite immunotherapy among age, gender and allergic disease populations, Int Arch Allergy Immunol, 160, 37, 10.1159/000339239 Van Metre, 1980, A controlled study of the effectiveness of the Rinkel method of immunotherapy for ragweed pollen hay fever, J Allergy Clin Immunol, 65, 288, 10.1016/0091-6749(80)90158-X Gehlhar, 1999, Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome, Clin Exp Allergy, 29, 497, 10.1046/j.1365-2222.1999.00525.x Francis, 2008, Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity, J Allergy Clin Immunol, 121, 10.1016/j.jaci.2008.01.072 Gould, 2008, IgE in allergy and asthma today, Nat Rev Immunol, 8, 205, 10.1038/nri2273 Gould, 2003, The biology of IGE and the basis of allergic disease, Annu Rev Immunol, 21, 579, 10.1146/annurev.immunol.21.120601.141103 Schulz, 1995, Der p I, a major allergen of the house dust mite, proteolytically cleaves the low-affinity receptor for human IgE (CD23), Eur J Immunol, 25, 3191, 10.1002/eji.1830251131 Gough, 1999, The cysteine protease activity of the major dust mite allergen Der p 1 selectively enhances the immunoglobulin E antibody response, J Exp Med, 190, 1897, 10.1084/jem.190.12.1897 Lalek, 2010, Immunoglobulin G-dependent changes in basophil allergen threshold sensitivity during birch pollen immunotherapy, Clin Exp Allergy, 40, 1186, 10.1111/j.1365-2222.2010.03524.x Inage, 2014, Critical roles for PU.1, GATA1, and GATA2 in the expression of human FcepsilonRI on mast cells: PU.1 and GATA1 transactivate FCER1A, and GATA2 transactivates FCER1A and MS4A2, J Immunol, 192, 3936, 10.4049/jimmunol.1302366 Bruhns, 2009, Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses, Blood, 113, 3716, 10.1182/blood-2008-09-179754 Mobs, 2008, Cellular and humoral mechanisms of immune tolerance in immediate-type allergy induced by specific immunotherapy, Int Arch Allergy Immunol, 147, 171, 10.1159/000142039 Pelaia, 2012, The potential of biologics for the treatment of asthma, Nat Rev Drug Discov, 11, 958, 10.1038/nrd3792 Buhl, 2002, Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma, Eur Respir J, 20, 73, 10.1183/09031936.02.00278102 Farne, 2017, Anti-IL5 therapies for asthma, Cochrane Database Syst Rev, 9 Tulaeva, 2020, Preventive allergen-specific vaccination against allergy: mission possible?, Front Immunol, 11, 1368, 10.3389/fimmu.2020.01368 Orengo, 2018, Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement, Nat Commun, 9, 1421, 10.1038/s41467-018-03636-8 Bernstein, 1979, Immunoregulatory function of specific IgG. II. Clinical evaluation of combined active and passive immunotherapy, Int Arch Allergy Appl Immunol, 58, 30, 10.1159/000232170 Bousquet, 1987, Combination of passive and active immunization in honeybee venom immunotherapy, J Allergy Clin Immunol, 79, 947, 10.1016/0091-6749(87)90245-4 Muller, 1986, Combined active and passive immunotherapy in honeybee-sting allergy, J Allergy Clin Immunol, 78, 115, 10.1016/0091-6749(86)90123-5 Flicker, 2013, Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy, Immunobiology, 218, 884, 10.1016/j.imbio.2012.10.008 Moerch, 2006, Allergen-specific polyclonal antibodies reduce allergic disease in a mouse model of allergic asthma, Int Arch Allergy Immunol, 140, 261, 10.1159/000093283 Shamji, 2021, Passive prophylactic administration with a single dose of anti-Fel d 1 monoclonal antibodies REGN1908-1909 in cat allergen-induced allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial, Am J Respir Crit Care Med, 204, 23, 10.1164/rccm.202011-4107OC Flicker, 2009, Placental transfer of allergen-specific IgG but not IgE from a specific immunotherapy-treated mother, J Allergy Clin Immunol, 124, 1358, 10.1016/j.jaci.2009.09.024 Glovsky, 1991, Effect of maternal immunotherapy on immediate skin test reactivity, specific rye I IgG and IgE antibody, and total IgE of the children, Ann Allergy, 67, 21